Nature 630 , 695703 (2024)
In a breakthrough study published in the prestigious journal Nature on March 18, 2026, scientists from the University of Rochesters Wilmot Cancer Institute have uncovered a previously uncharted role for glutathionea well-known antioxidantrevealing how cancer cells exploit this molecule not just for protection but as a critical fuel source
Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
It can have serious consequences on your health
Collagen Production- Collagen, a crucial protein for skin structure and elasticity, diminishes with age